Oncoliq is an Argentina-based biotechnology startup developing low-cost, non-invasive liquid-biopsy screening for early cancer detection
Oncoliq is an Argentina-based biotechnology startup developing low-cost, non-invasive liquid-biopsy screening for early cancer detection. Its approach detects cancer-associated microRNAs in small blood samples using optical molecular biosensors, with machine learning supporting detection and algorithm development. The company is developing multi-cancer early detection and patient follow-up applications.